Viral Diseases and Natural Products: Prospects in COVID-19 Treatment (Part V)
Curr Pharm Des
.
2022;28(12):947.
doi: 10.2174/138161282812220606124424.
Authors
Mohammad Amjad Kamal
1
2
3
4
,
Md Asaduzzaman Khan
5
Affiliations
1
Institutes for Systems Genetics, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, China.
2
King Fahd Medical Research Center, King Abdulaziz University, Saudi Arabia.
3
Department of Pharmacy, Faculty of Allied Health Sciences, Daffodil International University, Bangladesh.
4
Enzymoics, 7 Peterlee Place, Hebersham, NSW 2770; Novel Global Community Educational Foundation, Australia.
5
The Research Center for Preclinical Medicine, Southwest Medical University, China.
PMID:
35796442
DOI:
10.2174/138161282812220606124424
No abstract available
Publication types
Editorial
MeSH terms
Biological Products* / therapeutic use
COVID-19 Drug Treatment*
Humans
Phytotherapy
Virus Diseases*
Substances
Biological Products